These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

174 related items for PubMed ID: 9625391

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Simply stated...are people still wasting?
    Res Initiat Treat Action; 1998 Aug; 4(5):15. PubMed ID: 11365707
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. No attrition in research on wasting therapies.
    Gilden D.
    GMHC Treat Issues; 1997 Aug; 11(4/5):9, 12-6. PubMed ID: 11364378
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Effects of nandrolone decanoate compared with placebo or testosterone on HIV-associated wasting.
    Gold J, Batterham MJ, Rekers H, Harms MK, Geurts TB, Helmyr PM, Silva de Mendonça J, Falleiros Carvalho LH, Panos G, Pinchera A, Aiuti F, Lee C, Horban A, Gatell J, Phanuphak P, Prasithsirikul W, Gazzard B, Bloch M, Danner SA, E-1696 Study Investigators.
    HIV Med; 2006 Apr; 7(3):146-55. PubMed ID: 16494628
    [Abstract] [Full Text] [Related]

  • 10. Evaluation and treatment of weight loss in adults with HIV disease.
    Williams B, Waters D, Parker K.
    Am Fam Physician; 1999 Sep 01; 60(3):843-54, 857-60. PubMed ID: 10498111
    [Abstract] [Full Text] [Related]

  • 11. Beneficial effects of nandrolone decanoate in wasting associated with HIV.
    Saha B, Rajadhyaksha GC, Ray SK.
    J Indian Med Assoc; 2009 May 01; 107(5):295-9. PubMed ID: 19886384
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Appetite stimulants and anabolic steroid therapy for AIDS wasting.
    Saseen J, MacLaughlin EJ.
    AIDS Read; 1999 Sep 01; 9(6):398, 401-2, 407. PubMed ID: 12737131
    [No Abstract] [Full Text] [Related]

  • 14. Wasting and lipodystrophy in patients infected with HIV: a practical approach in clinical practice.
    Fisher K.
    AIDS Read; 2001 Mar 01; 11(3):132-3, 137-40, 147. PubMed ID: 17004351
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Weight loss update.
    PI Perspect; 1996 Nov 01; (No 20):18-9. PubMed ID: 11363968
    [Abstract] [Full Text] [Related]

  • 17. The use of testosterone in the AIDS wasting syndrome.
    Corcoran C, Grinspoon S.
    AIDS Clin Care; 1999 Apr 01; 11(4):25-6, 33-4. PubMed ID: 11366208
    [Abstract] [Full Text] [Related]

  • 18. Treatments for wasting in patients with the acquired immunodeficiency syndrome.
    Corcoran C, Grinspoon S.
    N Engl J Med; 1999 Jun 03; 340(22):1740-50. PubMed ID: 10352167
    [No Abstract] [Full Text] [Related]

  • 19. Weight loss and wasting in patients infected with human immunodeficiency virus.
    Grinspoon S, Mulligan K, Department of Health and Human Services Working Group on the Prevention and Treatment of Wasting and Weight Loss.
    Clin Infect Dis; 2003 Apr 01; 36(Suppl 2):S69-78. PubMed ID: 12652374
    [Abstract] [Full Text] [Related]

  • 20. The quality factor.
    HIV Hotline; 1998 May 01; 8(2):1-6. PubMed ID: 11365361
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.